BACKGROUND: Epigenetic variation is implicated in a range of non-communicable diseases, including those of the eye. However, investigating the role of epigenetic variation in ocular disease remains problematic as the degree of correlation in epigenetic profile between central (such as the brain or eye) and peripheral tissues (blood or saliva) within an individual remains largely unclear.
Introduction
The eye is the most specialised sensory organ in the human body. Light enters through the cornea and after passing through the pupil is finely focussed by the crystalline lens onto the neurosensory retina. Initiation of the phototransduction cascade converts the photonic energy into a neural signal, and following a high degree of pre-retinal processing, this signal is transferred via retinal ganglion cells to the brain [1] . Retinal ganglion cells exit the eye thorough the optic nerve to synapse in the mid-brain [1] . Stray light is absorbed by the retinal pigmented epithelium (RPE), which also serves a fundamental role in vitamin A cycling [2] . The high metabolic demand of phototransduction is ameliorated by the cavernous choroidal tissue which is located posterior to the RPE and receives the highest blood flow per tissue volume in the body [2] .
Dysfunction of almost any cellular component of the eye can lead to significant visual morbidity.
Many ophthalmic diseases are known to have both heritable and environmental pathoaetiological factors, [3] and a greater understanding of the molecular mechanisms of ophthalmic disease have revolutionised therapy [4, 5] . Although much insight into the genetic causes of ocular disease have been gained through well powered genome-wide association and linkage studies, [6] the precise means by which genetic variants and environmental stressors interact remain poorly understood.
These dynamic interactions, which have cellular consequences, can be broadly categorised as epigenetic variation. Understanding the epigenetic factors involved in ophthalmic disease may facilitate the development of novel disease screening and therapeutic avenues.
Epigenetic variation has emerged as a major mediator of gene:environment interactions thought to underpin much of human disease. However, unlike genetic variation, epigenetic processes are dynamic both temporally and spatially, with each specific tissue type displaying a unique epigenetic profile. DNA methylation is by far the most widely studied epigenetic process due to its ease of measurement and high degree of stability in biological specimens, and many studies have begun to explore the link between DNA methylation variation and a range of exposures and disease outcomes. Although the field of epigenetic-epidemiology remains in its infancy, some compelling findings have emerged, particularly in relation to the effects of tobacco smoking exposure on DNA methylation profile in blood and buccal cells. A clearer understanding of the methylation landscape of tissues relevant to specific conditions is required in order to gain insights into the relevance of measuring epigenetic profile in a proxy tissue such as blood or saliva [7] . This has already been extensively examined in matched blood and brain [8] [9] [10] , but has yet to be investigated in matched blood and eye tissue.
The principal aim of this study was to investigate the methylation profiles of specific ocular tissues, and compare this profile to matched peripheral blood in order to assess the utility of blood DNA methylation profile as a proxy for the direct study of eye tissue -not possible in living humans.
Herein, we determine the relative importance of ocular tissue methylation specificity at the genomewide level, and quantify the number of sites that co-vary within an individual across neurosensory retinal, RPE/choroidal and optic nerve tissue.
METHODS

Sample collection and processing
Whole blood from the subclavian vein and whole eyes were obtained post-mortem. The donors had no known ophthalmic disease. Donors previously diagnosed with disseminated cancer were excluded. Specimens from eight people were available. These donors were all male and the mean (SD) age was 60.6 (11.3) years ( Supplementary Table 1 ).
Blood samples were collected in tubes containing EDTA. All ocular tissue was collected and stored within twelve hours post-mortem. A circumferential pars plana incision was made and the vitreous body discarded. The neurosensory retina was removed and the RPE and choroid were dissected free from the scleral wall. Dura matter was stripped from the anterior segment of optic nerve before storage. Dissected ocular tissue was stored in QIAGEN Allprotect Tissue Reagent (QIAGEN, Hiden, Germany) and DNA extraction was subsequently performed using the QIAGEN DNeasy This study was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent revisions.
Methylation data preprocessing
Quality control and background correction of the Beadstudio data was performed using the R programming software (version 3.2.1, http://cran.r-project.org/) ChAMP Bioconductor package, which utilises the minfi package [11] . Normalisation was performed on all samples using the betamixture quantile normalisation method, a comparably robust normalisation method which adjusts the beta-value distribution of type II probes to resemble that of type I probes [12] . Probes that had a detection p-value greater than 0.01, probes that were cross-reactive, and probes that potentially contained SNPs of high minor allele frequency [13] , were removed from the dataset. As samples were all male, probes that hybridise to sex chromosomes were retained, leaving a total of 433,768 probes. Batch adjustment for samples was performed using the sva R package.
Data processing and statistical analysis
All statistical analysis was performed in R. Unsupervised hierarchical clustering was first performed to investigate the relationships between samples. 
Methylation levels between individuals and tissues for all
Correlation between tissues
Subsequent analysis utilized probes that were 'blood variable', defined as having >5% methylation range within the inner 80 th percentile of probes. The association of methylation levels between tissues within individuals was calculated for each CpG site using Spearman correlations. To establish the existence of an association in methylation levels between tissues, the correlation distribution was compared to a null correlation distribution, which was simulated by permuting samples and calculating correlations between unmatched pairs. Paired t-tests with matched samples were used to identify the most similarly methylated probes between tissues.
Principal components analysis
To further investigate the structure of variation within the dataset, principal components analysis was performed on normalised M-values. Principal components were analysed for correlation with sample traits (e.g. tissue type, individual), using both linear regression and ANOVA. Probes that are associated with trait-related principal components contribute to the pattern of variation and likely vary across the trait.
As we were mainly interested in inter-individual differences across tissue type, probes that were highly associated with individual-associated principal components (|r| > 0.5) were selected for further analysis. Four principal components were found to vary between individuals only at a p < 0.10 level, accounting for 10.8% of the total variation. Hierarchical clustering was performed with probes related to these principal components, both combined and separately, and with and without the removal of tissue-specific probes. As there was little gene overlap between individual-specific and tissue-specific probes, the removal of tissue-specific probes had no significant effect on clustering. Only one principal component was significantly associated with inter-individual difference at p < 0.05. Probes that correlate with this principal component (PC13) were then compared with probes that co-vary between tissues.
Gene annotation and genomic enrichment
Probes were categorised into genomic features and CpG island features according to the annotation file provided for Illumina. Enrichment within each category was investigated for all probes, blood variable probes, blood variable probes that correlate with each eye tissue (|r| > 0.5, p < 0.05), and probes that correlate with individual-related principal components.
Gene ontology and Pathway analysis
Ingenutity Pathway Analysis (IPA) was used to investigate cellular pathways subject to DNA methylation variation. Gene ontology enrichment analysis was assessed using the PANTHER Overrepresentation Test (release 20160715) as part of the Gene Ontology Consortium (www.geneontology.org). HM450K probes located in a gene, or within 2kb of the transcription start site showing differential methylation were assigned to the annotated gene. Genes on the HM450K array were used as the background list against which a target list were analysed.
RESULTS
Sources of variation within the dataset
Following quality control and data normalization, DNA methylation values from a total of 433,768 probes were available for use in analysis. As anticipated, unsupervised hierarchical clustering revealed tissue type as the main driver of variation within the dataset, blood had the most distinct methylation profile, while RPE/choroid and optic nerve were the most similar (Figure 1) .
Multidimensional Scaling plot visualisation of the 1,000 most variable probes highlighted the similarity of RPE/choroid and optic nerve methylation profiles relative to retina, with blood the most dissimilar in methylation profile (Supplementary Figure 1) .
To further dissect the source(s) of methylation variation within the dataset, we performed principal component analysis. As expected, most of the variation within the dataset (55.84%) was due to tissue type, with the first four principal components (PCs) all associated with tissue of origin at p < 0.05 (Figure 2) . The only PC of variation that exclusively associated with individuals at p < 0.05 was PC13, comprising 802 probes that account for 1.87% of the variance within the dataset (Supplementary Table 2 ). Hierarchical clustering using probes associated with PC13 showed a clear separation of most individuals as predicted, despite very similar methylation levels across individuals overall (Supplementary Figure 2) . Correlation analysis confirmed that PC13 was not related to any measured phenotype, such as age at death and cause of death (not shown).
Correlation of methylation values within and between tissues
Despite this discrete clustering, and reflecting the large number of CpG sites analysed, there was generally a strong correlation between methylation across all samples, with a median Spearman correlation of 0.914 (range: 0.819 -0.987). Blood methylation profile had the strongest correlation with RPE/choroid (median r = 0.913, range: 0.892 -0.939; not shown), followed by optic nerve (median, range) (not shown) and retinal tissue (median r = 0.850, range: 0.819 -0871; not shown), .
Methylation β-values were bimodally distributed, with the majority of sites being commonly hypomethylated (β ≤ 0.2) or hypermethylated (β ≥ 0.8) across all tissues (Supplementary Figure   3) . In order to explore this further, we divided probes into three categories of hypo (β ≤ 0.2), intermediate (0.2 < β <0.8) and hypermethylated (β ≥ 0.8) and then assessed the degree of overlap in each class of probe across all tissues tested. This approach confirmed that the majority of methylation is relatively consistent across all tissues, though considerable evidence of tissue-oforigin methylation levels is also present within all 3 broad methylation classes (Figure 3) .
Interestingly, each of the ocular tissues examined also shared a uniquely overlapping set of methylation levels with blood rather than other eye tissues (Figure 3) .
We were primarily interested in identifying CpG sites where inter-individual variation in blood was also associated with inter-individual differences in eye methylation. Such probes may represent reliable proxy measures for variation in ocular methylation, measurable in peripheral blood. To investigate this, pairwise correlation analysis was performed for each probe within a subset identified as variable in blood across individuals, defined as those for which the inter-individual methylation difference between the 10 th and 90 th percentiles was > 5% (224,417 probes in total).
The distribution of correlations between matched samples was compared with a randomly permuted distribution (i.e. null) to establish the degree of relatedness between blood and eye methylation levels. Significant differences were found between the true and null distributions (Wilcoxon rank test p < 2.2 x10 -16 for all tissues (not shown)). Interestingly, most of the probes that were correlated or anti-correlated (Spearman r > 0.5, p < 0.05) between blood and eye tissues within an individual were unique for each pairwise tissue comparison, with only 122 probes commonly correlated with blood across all three eye tissues. Hierarchical clustering using these commonly variable probes revealed that retina and blood samples still cluster primarily by tissue, whereas RPE/choroid and optic nerve samples cluster by individual as opposed to tissue type (Supplementary Figure 4) .
Thus, these probes in isolation are of limited utility in inferring general ocular methylation status from blood.
Genomic context of variable probes
Compared to the overall distribution of probes, those showing inter-individual variation in blood were enriched for intergenic regions and CpG 'open seas' (Figure 4) . The genomic distribution of PC13-related probes appeared to be closer to the overall distribution, rather than blood-variable probes, being enriched at sites within 200bp of transcription start sites, and also in CpG islands.
This suggests that probes that vary between individuals do not necessarily co-vary between tissues types within an individual. Of 802 probes associated with PC13, 281 showed variable methylation in blood of different individuals, and of those, 115 showed correlated methylation with one or more eye tissues within an individual.
Gene Pathway and ontology Analysis
The 802 probes associated with PC13 were linked to 541 genes. The potential for epigenetic variation to play a role in diseases of the eye has been suggested for several years, with various explorations in blood or saliva in individuals with conditions such as macular degeneration or retinitis pigmentosa. Recently, the potential for DNA methylation to play a role in Age-related Macular Degeneration (AMD) has been directly investigated through the genome-wide DNA methylation profiling of blood from AMD patients and controls. Small but replicable differences in DNA methylation were identified in the blood of neovascular AMD patients near the age-related maculopathy susceptibility 2 (ARMS2), gene, previously linked to AMD in genome-wide association studies (GWAS). Interestingly, an integrated analysis of blood and retina further identified consistent DNA methylation variation in the protease serine 50 (PRSS50) gene [14] .
Genetic variation at methylation quantitative trait loci (mQTLs) plays a major role in shaping the human DNA methylation profile, including the potential modulation of the effects of environmental exposures on methylation variation. Although some mQTLs are likely tissue specific in their influence on methylation, others are likely conserved across tissues with their effects measureable in tissues such as blood. Evidence in support of a combined effect of genetic and epigenetic variation has also been implicated in AMD with evidence of an association with underlying genotype of the risk SNP rs10490924 with disease-associated variation in ARMS2 methylation [14] .
In many large epidemiological studies, whole blood is the only biological material that has been archived. The extent to which the DNA methylation patterns of easily accessible tissues like whole blood represent the epigenetic phenotype in inaccessible tissues is unclear, although recent studies are showing a certain degree of concordance. Epigenetic variation arising before disease could be inherited and thus be present in all adult tissues, or it could arise stochastically during the lifecourse and be limited to one, or a few tissues. Epigenetic variation can also be environmentally induced by life-style related factors, such as diet or smoking. In support of this, a panel of metastable epialleles has recently been described in humans that show inter-individual variation apparently independent of tissue of origin [15] . Such loci have considerable potential to act as epigenetic 'sensors' of past environmental influence/exposure.
In the current study, we defined the DNA methylation profile of 3 ocular tissues and compared these directly to matched peripheral whole blood from the same individuals. Despite a largely concordant methylation profile, only limited instances of correlated variation between tissues within specific individuals were observed. Collectively, our data support recent findings in similar analyses of the brain that suggested EWAS approaches using whole blood for disorders of the brain are likely to be of only limited utility for discovery type approaches aimed at unravelleing disease aetiolgoy [8] . Nevertheless, as with our findings in the eye, there are a proportion of sites where inter-individual variation is correlated between whole blood and brain, highlighting the utility (albeit limited with the current platform) of using a blood-based EWAS to identify potential biomarkers of disease of more central tissues such as the brain and the eye.
There are some caveats to the use of peripheral blood leukocytes to study DNA methylation profiles. Firstly, like neurosensory retinal and RPE/choroidal tissue, peripheral blood comprises a heterogeneous cell population. Therefore, any observed variation in DNA methylation assessed in whole blood may reflect small changes in the proportions of differentially methylated cell types that may in turn vary between individuals. A further limitation involves the issue of timing. It is now apparent that the DNA methylation of whole blood is altered with ageing and therefore samples taken from the same individual might be different if taken a few years apart. Equivalent data are generally not available for more central tissues of CNS or ocular origin. This has considerable potential to confound interpretation of EWAS studies. Figure 3 . Distribution of mean HM450K methylation -values (in 5% bins) across each tissue tested in the current study. All tisseus show a bimodal distribution. X-axisvalues correspond to methylation levels approximating 0-100%. Y-axis is the frequency of probes within each bin.
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